Related Experiment Video
Updated: Aug 23, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Coronary thrombolysis with tissue-type plasminogen activator: prospective review
1Center for Thrombosis and Vascular Research, Department of Medical Research, University of Leuven, Belgium.
Abstract:
Coronary thrombolysis is not a goal in itself, but is employed to prevent necrotic dysfunction of jeopardized myocardial cells. It is being increasingly investigated as a treatment for acute myocardial infarction, which is often associated with thrombotic occlusion of an atherosclerotic coronary artery. The administration of thrombolytic agents has been shown to reopen an occluded coronary artery in the majority of such cases. Briefly summarized are studies performed to date in animal models and in patients with acute myocardial infarction.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Clot Retraction and Fibrinolysis
